Pancreatic Cancer Research

ResearcherWuhan Union HospitalActive in the last 2 years

Yuhang Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-0599-2941; OpenAlex author ID A5103957943. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. Targeting Lactate-Driven Stromal Autophagy via MCT1 Disrupts the Immunosuppressive Niche and Sensitizes Pancreatic Cancer to PD-1 Blockade. Co-author DOI 10.1002/advs.76008↗
  2. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of … Co-author DOI 10.1186/s13046-022-02285-6↗
  3. Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Co-author DOI 10.1038/s41388-021-01960-w↗
  4. LncRNA ZNFTR functions as an inhibitor in pancreatic cancer by modulating ATF3/ZNF24/VEGFA pathway. Co-author DOI 10.1038/s41419-021-04119-3↗
  5. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway. Co-author DOI 10.1158/0008-5472.can-21-0281↗
  6. LncRNA-ZFAS1 Induces Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells During Nutrient Deprivation by Promoting AMPK-Mediated Phosphorylation and St… Co-author DOI 10.21203/rs.3.rs-875697/v1↗
  7. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer. Co-author DOI 10.7150/thno.49147↗
  8. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α. Co-author DOI 10.7150/thno.34559↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gang Zhao · 6 shared papers, 2019–2026 · strength 0.76
  2. Fengyu Xu · 7 shared papers, 2019–2022 · strength 0.76
  3. Zhu Zeng · 6 shared papers, 2019–2022 · strength 0.65
  4. Wenfeng Zhuo · 2 shared papers, 2022–2026 · strength 0.39
  5. Chunyou Wang · 4 shared papers, 2019–2021 · strength 0.38
  6. Wei Li · 2 shared papers, 2020–2021 · strength 0.21
  7. Peng Xu · 2 shared papers, 2020–2021 · strength 0.19
  8. Ye Zeng · 2 shared papers, 2019–2021 · strength 0.18
  9. Gang Zhao · 1 shared paper, 2022 · strength 0.14
  10. Gang Zhao · 1 shared paper, 2021 · strength 0.11
  11. Shuai Zhu · 1 shared paper, 2021 · strength 0.10
  12. Zhi Fang Ma · 1 shared paper, 2020 · strength 0.09
  13. Shi-Jiang Deng · 1 shared paper, 2019 · strength 0.08
  14. Mingliang Liu · 1 shared paper, 2019 · strength 0.08
  15. Wei Li · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.